USPTO Assignments on the Web

	United States Patent and Trademark Office
	Home\|Site Index\|Search\|Guides\|Contacts\|eBusiness\|eBiz alerts\|News\|Help

Patent Assignment Details

NOTE:Results display only for issued patents and published applications. For pending or abandoned applications please consult USPTO staff.

Reel/Frame:	031534/0920			Pages:	8
		Recorded:	11/04/2013
Attorney Dkt #:	067802
Conveyance:	ASSIGNMENT OF ASSIGNORS INTEREST (SEE DOCUMENT FOR DETAILS).

Total properties: 11

Patent #:	6610820	Issue Dt:	08/26/2003	Application #:	09503954	Filing Dt:	02/14/2000
Title:	CELL-PERMEABLE PEPTIDE INHIBITORS OF THE JNK SIGNAL TRANSDUCTION PATHWAY

Patent #:	6780970	Issue Dt:	08/24/2004	Application #:	09970515	Filing Dt:	10/03/2001
Publication #:	US20020127676	Pub Dt:	09/12/2002
Title:	CELL-PERMEABLE PEPTIDE INHIBITORS OF THE JNK SIGNAL TRANSDUCTION PATHWAY

Patent #:	8183339	Issue Dt:	05/22/2012	Application #:	10110430	Filing Dt:	08/27/2002
Title:	CELL-PERMEABLE PEPTIDE INHIBITORS OF THE JNK SIGNAL TRANSDUCTION PATHWAY

Patent #:	8080517	Issue Dt:	12/20/2011	Application #:	11224159	Filing Dt:	09/12/2005
Publication #:	US20070060514	Pub Dt:	03/15/2007
Title:	CELL-PERMEABLE PEPTIDE INHIBITORS OF THE JNK SIGNAL TRANSDUCTION PATHWAY

Patent #:	8748395	Issue Dt:	06/10/2014	Application #:	12066657	Filing Dt:	11/11/2008
Publication #:	US20090305968	Pub Dt:	12/10/2009
Title:	CELL-PERMEABLE PEPTIDE INHIBITORS OF THE JNK SIGNAL TRANSDUCTION PATHWAY

Patent #:	9006185	Issue Dt:	04/14/2015	Application #:	12995192	Filing Dt:	04/15/2011
Publication #:	US20110183888	Pub Dt:	07/28/2011
Title:	USE OF CELL-PERMEABLE PEPTIDE INHIBITORS OF THE JNK SIGNAL TRANSDUCTION PATHWAY FOR THE TREATMENT OF VARIOUS DISEASES

Patent #:	9180159	Issue Dt:	11/10/2015	Application #:	12995197	Filing Dt:	04/15/2011
Publication #:	US20110207677	Pub Dt:	08/25/2011
Title:	Use of Cell-Permeable Peptide Inhibitors of the JNK Signal Transduction Pathway for the Treatment of Chronic or Non-Chronic Inflammatory Digestive Diseases

Patent #:	8278413	Issue Dt:	10/02/2012	Application #:	13222115	Filing Dt:	08/31/2011
Publication #:	US20120142613	Pub Dt:	06/07/2012
Title:	CELL-PERMEABLE PEPTIDE INHIBITORS OF THE JNK SIGNAL TRANSDUCTION PATHWAY

Patent #:	NONE	Issue Dt:		Application #:	13244582	Filing Dt:	09/25/2011
Publication #:	US20120148590	Pub Dt:	06/14/2012
Title:	CELL-PERMEABLE PEPTIDE INHIBITORS OF THE JNK SIGNAL TRANSDUCTION PATHWAY

Patent #:	8981052	Issue Dt:	03/17/2015	Application #:	13805758	Filing Dt:	03/11/2013
Publication #:	US20130172530	Pub Dt:	07/04/2013
Title:	Novel JNK Inhibitor Molecules

Patent #:	9150618	Issue Dt:	10/06/2015	Application #:	13879059	Filing Dt:	09/05/2013
Publication #:	US20130337557	Pub Dt:	12/19/2013
Title:	USE OF CELL-PERMEABLE PEPTIDE INHIBITORS OF THE JNK SIGNAL TRANSDUCTION PATHWAY FOR THE TREATMENT OF CHRONIC OR NON-CHRONIC INFLAMMATORY EYE DISEASES

Assignor

Exec Dt:

08/23/2013

Assignee

ARCH. MAKARIOU III

195 NEOCLEOUS HOUSE

LIMASSOL, CYPRUS 3030

Correspondence name and address
	Y. HARRY DU
	MORGAN, LEWIS & BOCKIUS LLP
	1111 PENNSYLVANIA AVENUE, N.W.
	WASHINGTON, DC 20004

Search Results as of: 06/03/2024 09:23 AM

If you have any comments or questions concerning the data displayed, contact PRD / Assignments at 571-272-3350. v.2.6

Web interface last modified: August 25, 2017 v.2.6